We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$45.1M
1-Year Est. Return
74.25%
This Fund
S&P 500
This Quarter
Est. Return
-5.44%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$1.92B
AUM Growth
-$82.3M
(-4.1%)
Cap. Flow
-$215M
Cap. Flow
% of AUM
-11.22%
Top 10 Holdings %
Top 10 Hldgs %
52.67%
Holding
387
New
94
Increased
95
Reduced
80
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$12.5M |
| 2 |
Abbott
ABT
|
+$10.5M |
| 3 |
Outlook Therapeutics
OTLK
|
+$7.71M |
| 4 |
BPTH
Bio-Path Holdings Inc
BPTH
|
+$7.56M |
| 5 |
SHPG
Shire pic
SHPG
|
+$5.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$22.6M |
| 2 |
Biogen
BIIB
|
+$7.14M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.88M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$3.22M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Industrials | 0.12% |
| 3 | Consumer Staples | 0.07% |
| 4 | Consumer Discretionary | 0.06% |
| 5 | Technology | 0.03% |
Similar funds
CG
OC
ICCON
PCM
CAS
CM
MCMC
CTC
Sabby Management's Q2 2016 Portfolio in Review
As of Q2 2016, Sabby Management held 387 positions worth $1.92B, down 4.1% from $2B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Sabby Management withdrew a net $215M in Q2 2016, closing 99 positions and reducing 80 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $22.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Sabby Management opened a new position in Abbott worth $10.4M.
- Sabby Management's largest Q2 2016 buy was Abbott: 264,700 shares worth $10.4M.
- Sabby Management added most to Regeneron Pharmaceuticals in Q2 2016, an estimated $12.5M increase.
- Sabby Management's biggest Q2 2016 reduction was Biogen, cutting an estimated $7.14M.
- Sabby Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2016, selling an estimated $22.6M.
- Sabby Management's ten largest holdings make up 53% of its $1.92B portfolio in Q2 2016.
- Sabby Management opened 94 new positions and closed 99 in Q2 2016.
- Sabby Management's portfolio value fell 4.1% quarter-over-quarter to $1.92B.
Based on Sabby Management's 13F filing for Q2 2016, filed 15 Aug 2016.